phentermine

Qnexa FDA weight loss pill NOT recommended for approval by committee-July 15, 2010

woman with bookWill Qnexa be recommended for approval by the FDA?

The FDA advisory committee which reviewed Endocrine and Metabolic medicines met on Thursday, July 15th to review QNEXA, a new weight loss medicine which combines phentermine and topiramate in a single pill. the committee was concerned about benefits versus risks and did NOT recommend that the medicine be approved.

Approval Date: 
Thu, 07/15/2010
Company: 
Vivus

This website is not intended as medical advice, and you should consult your doctor before changing or adding any medicines or vitamins to those you may now be taking and about applying any strategies BEFORE you adopt any approach in this report. While diligent care has been taken to ensure the accuracy of the information provided during the preparation of this edition, no claim is made that all known actions, uses or side effects, strategies for cost containment, targets or cholesterol pathways are included in this report. The accuracy and currentness of information are ever subject to change relative to new guidelines, new information derived from drug research, development and general usage.